Philip Haywood, PhD is a clinician and academic with extensive cross disciplinary experience from medical, policy and economic perspectives. He worked for over a decade in the emergency department at Newcastle’s Calvary Mater Hospital. His PhD was in the use of administrative data to support an outcome based funding model. As an economist, Phil has investigated the integration of hospital level cancer registries for NSW Health. At the OECD he researched how different countries have approached the introduction of new technologies. In Australia, Phil was involved in producing NHMRC guidelines for lung cancer and economic evaluations. Phil has been involved in trial design and evaluation of new technologies in health care. His focus is on producing economic evidence for real world decision making with an emphasis on the introduction of new technologies. He now serves on the protocol advisory sub-committee for the Medical Services Advisory Committee. He has acted as a clinical advisor to the CHERE economic evaluation team for a decade.